Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous-oral stepdown program

Annals of Pharmacotherapy

Volumn 30, Issue 4, 1996, Pages 337-342

  Malfair, Suzanne C ^a,b   Frighetto, Luciana ^a,c   Nickoloff, Donna M ^a,d   Martinusen, Shelagh M ^a   Jewesson, Peter J ^a  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Campbell River and District Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFALEXIN; CEFUROXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN V;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANADA; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG COST; DRUG FORMULATION; FEMALE; HUMAN; HUMAN TISSUE; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029960880     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809603000402     Document Type: Article

References (17)

1. Kohl FV. A multicentre clinical trial to compare two antibiotic regimens in patients with LRTIs: cefuroxime IV followed by cefuroxime axetil versus cefotiam IV (abstract). Proceedings of the 17th International Congress of Chemotherapy, Berlin, Germany, June 23-28, 1991.
2. Brambilia C, Latronche CHU, Kastanakis S. Cefuroxime versus Augmentin follow-on therapies in the treatment of lower respiratory tract infections (abstract). Proceedings of the 17th International Congress of Chemotherapy. Berlin, Germany, June 23-28, 1991.
3. Kastanakis S. A comparative study of amoxicillin and clavulanic acid (IV then oral) versus IV cefuroxime, followed by cefuroxime axetil in the treatment of lower respiratory tract infections (abstract). Proceedings of the 17th International Congress of Chemotherapy, Berlin, Germany, June 23-28, 1991
4. Frighetto L, Nickoloff D, Martinusen SM, Mamdani FS, Jewesson PJ. Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital. Ann Pharmacother 1992;26:1447-51.
5. Jewesson P. Cost-effectiveness and value of an IV switch. Pharmacoeconomics 1994;5(suppl 2):20-6.
6. Frighetto L, Martinusen S, Mamdani F, Jewesson P. Assessment of ciprofloxacin use under the influence of a reserved antimicrobial program and parenteral-oral stepdown program at a major Canadian hospital Can J Hosp Pharm 1995;48.35-42.
7. Mandell LA, Bergeron MG, Ronald AR, Vega C, Harding G, Saginur R, et al. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. J Infect Dis 1989;160:433-41.
8. Product information. Ceftin (cefuroxime). Toronto: Glaxo Canada, June 20, 1990.
9. Ariano RE, Zhanel GG. Antimicrobial prophylaxis in coronary bypass surgery: a critical appraisal. DICP Ann Pharmacother 1991;25:478-84.
10. Kaiser AB. Antimicrobial prophylaxis in surgery. N Engl J Med 1986;315:1129-38.
11. Kunin CM. Evaluation of antibiotic usage: a comprehensive look at alternative approaches. Rev Infect Dis 1981;3:745-53.
12. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992;326:281-6.
13. Abramowicz M. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 1989;31:105-8.
14. Miedzinski LJ, Callaghan JC, Fanning EA, Gelfand ET, Goldsand G, Modry D, et al. Antimicrobial prophylaxis for open heart operations. Ann Thorac Surg 1990;50:800-7.
15. Bunz DM, Frighetto L, Gupta S, Jewesson PJ. Simple ways to promote cost containment (letter). DICP Ann Pharmacother 1990;24:546.
16. Martinusen S, Chen D, Frighetto L, Bunz D, Stiver G, Jewesson P. A comparison of cefoxitin and ceftizoxime in a hospital therapeutic interchange program. Can Med Assoc J 1993;148:1161-9.
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a seventy of disease classification system. Crit Care Med 1985;13:818-29.